Familial Transthyretin AmyloidosisSymptoms, Doctors, Treatments, Advances & More
Familial Transthyretin Amyloidosis Overview
Learn About Familial Transthyretin Amyloidosis
- Familial transthyretin amyloidosis
- Amyloidosis Transthyretin related
- Amyloidosis, hereditary, transthyretin-related
- Familial amyloid polyneuropathy
- Hereditary ATTR amyloidosis
- TTR amyloid neuropathy
- Transthyretin amyloid neuropathy
- Transthyretin amyloid polyneuropathy
- Transthyretin amyloidosis
Johns Hopkins Bayview Medical Center
Michael Polydefkis is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Polydefkis is rated as an Elite provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy. Dr. Polydefkis is currently accepting new patients.
CUIMC/Vivian & Seymour Milstein Family Heart Center
Mathew Maurer is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist practicing medicine in New York, New York. Dr. Maurer is rated as an Elite provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Maurer is board certified in Advanced Heart Failure And Transplant Cardiology, Cardiovascular Disease, and Internal Medicine. Dr. Maurer is currently accepting new patients.
Pablo Pavia-Garcia practices practicing medicine in Pozuelo De Alarcon, Spain. Mr. Pavia-Garcia is rated as an Elite expert by MediFind in the treatment of Familial Transthyretin Amyloidosis. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloid Cardiomyopathy, Cardiomyopathy, Transthyretin Amyloidosis, Heart Transplant, and Pacemaker Implantation.
Summary: This study will be conducted to evaluate the efficacy and safety of a single dose of nexiguran ziclumeran (NTLA-2001) compared to placebo in participants with ATTRv-PN.
Summary: The aim of the study is to evaluate coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and proportion of overt microvascular disease, defined as depressed CFR as well as elevated IMR in patients with cardiac amyloidosis. The second objective of this study is to compare results of non-invasive test including serum light chain amount, Doppler echocardiography with 2D strain, an...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


